COVALENT-102: A Phase 1/1b study of BMF-219, a menin inhibitor in patients with unresectable, metastatic NSCLC, PDAC, and CRC
BMF-219
Below is an instruction that describes a task, paired with an input that provides further context. Write a response that appropriately completes the request. ### Instruction: Identify all the mentioned drugs in the given text. Text may or may not contain drug. If they contain more than 1 drug, use ";" as delimiter and join them. ### Input: COVALENT-102: A Phase 1/1b study of BMF-219, a menin inhibitor in patients with unresectable, metastatic NSCLC, PDAC, and CRC ### Output: BMF-219